|4Jul 18, 4:00 PM ET

Dhanak Dashyant 4

4 · INCYTE CORP · Filed Jul 18, 2023

Insider Transaction Report

Form 4
Period: 2023-07-14
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2023-07-14+8,05658,968 total
  • Award

    Employee Stock Option (right to buy)

    2023-07-14+16,89616,896 total
    Exercise: $61.76Exp: 2033-07-13Common Stock (16,896 underlying)
Footnotes (3)
  • [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  • [F2]Including the July 14, 2023 RSU Grant, this includes an aggregate of 53,279 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
  • [F3]The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION